CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue:
Total revenue	$ 76,372	$ 90,059
Expenses:
Selling, general and administrative	19,735	6,492
Research and development	12,588	5,838
Amortization of acquired intangible assets	3,805	0
Loss on extinguishment of debt	0	20,662
Changes in fair values of equity method investments, net	(15,817)	11,950
Changes in fair values of other equity and long-term investments, net	2,164	(2,539)
Interest and dividend income	(3,365)	(322)
Interest expense	4,427	3,010
Other expense, net	1,346	250
Total expenses	35,232	45,341
Income before income taxes	41,140	44,718
Income tax expense, net	6,275	6,860
Net income	34,865	37,858
Net income attributable to noncontrolling interests	0	22,085
Net income attributable to Innoviva stockholders	$ 34,865	$ 15,773
Basic net income per share attributable to Innoviva stockholders	$ 0.51	$ 0.23
Diluted net income per share attributable to Innoviva stockholders	$ 0.42	$ 0.20
Shares used to compute Innoviva basic and diluted net income per share:
Shares used to compute basic net income per share	67,786	69,544
Shares used to compute diluted net income per share	89,788	93,730
Royalty revenue
Revenue:
Total revenue	$ 56,858	$ 90,059
Net product sales
Revenue:
Total revenue	11,514	0
Expenses:
Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding depreciation and amortization of intangible assets)	8,749	0
License revenue
Revenue:
Total revenue	8,000	0
License
Expenses:
Cost of license revenue	$ 1,600	$ 0